SCHEMBL2184411

SCHEMBL2184411

CN(C)CCCNc1nnc2c(n1)c(=O)n(C)c(=O)n2Cc1cccnc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HIF1A Q16665 4/20 0.40
HTT P42858 1/20 0.40
PARG Q86W56 2/20 0.39
MAPK1 P28482 1/20 0.39
RAD52 P43351 1/20 0.39
GRIN1 Q05586 5/20 0.38
GRIN2B Q13224 5/20 0.38
GAA P10253 1/20 0.38
PKM P14618 2/20 0.38
LMNA P02545 2/20 0.38
KDM4E B2RXH2 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2183235 0.94 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2C9
SCHEMBL2183762 0.94 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2C9
SCHEMBL2182004 0.91 EGFR (0.41) ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2C9
SCHEMBL2181789 0.91 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2C9
SCHEMBL2184025 0.89 PCSK9 (0.41) ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2C9
SCHEMBL2182059 0.89 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2C9
SCHEMBL2180765 0.89 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2C9
SCHEMBL2179044 0.87 HIF1A (0.42) ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2C9
SCHEMBL2183656 0.87 HIF1A (0.39) ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2C9
SCHEMBL2183194 0.87 THRB (0.46) ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-07-07 US disclosed
WO-2010014798-A2 PYRIMIDOTRIAZINEDIONES AND PYRIMIDOPYRIMIDINEDIONES AND METHODS OF USING THE SAME THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2010-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same DPYD, TYMP, DHFR ALDH1A1 245/4885SMN1; SMN2 2741/4885CYP1A2 1149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.